![]() |
市場調查報告書
商品編碼
1567779
北美水生獸醫市場預測至 2030 年 - 區域分析 - 按類型、診斷、治療、物種、疾病來源和給藥途徑North America Aquatic Veterinary Market Forecast to 2030 - Regional Analysis - by Type, Diagnostic, Treatment, Species, Diseases Source, and Route of Administration |
2022年北美水生獸醫市場估值為5.5703億美元,預計到2030年將達到7.5198億美元;預計2022年至2030年複合年成長率為3.8%。
政府發展水產養殖業的措施推動北美水產獸醫市場
對海鮮的高需求和野生魚類年捕撈量的下降是推動水產養殖業呈指數級成長的關鍵因素。因此,各國政府正採取措施改善和支持水產養殖業的發展。以下是最近的一些舉措:
2021年2月,食品與農業研究基金會(FFAR)籌集了790,326美元資金,用於創建疫苗輸送系統,以防止羅非魚湖病毒感染和其他疾病在水產養殖領域的傳播。
Sea Grant 海洋水產養殖資助計劃:這項全國性的競爭性資助計劃,正式名稱為“國家海洋水產養殖計劃 (NMAI)”,旨在促進研究和示範計劃,以推動美國永續海水養殖。
2022 年,美國農業部國家食品和農業研究所 (NIFA) 宣布投資超過 1,300 萬美元,用於研究動物疾病的新療法和預防措施,這些疾病給全球農業部門帶來了數十億美元的損失。其中包括向密西西比州立大學撥款 625,000 美元,用於評估一種抗菌飼料添加劑,該添加劑可用於以安全有效的方式預防鯰魚腸敗血症。這項研究將有助於開發水產養殖生產者的處理替代方案,並提高生產效率。因此,政府支持水產養殖業發展的舉措的增加推動了水產獸醫市場的成長。
北美水產獸醫市場概況
據美國國家海洋和大氣管理局稱,美國水產養殖每年創收約 15 億美元。世界銀行表示,美國透過水產養殖生產了約 44.8 萬噸產品。據同一來源稱,2021年北美水產養殖業生產了約560萬條魚類,其中美國產量約470萬條,即佔該地區魚類總產量的約83%。根據《2020 年美國漁業報告》,2020 年美國商業漁民捕獲了84 億英鎊,價值47 億美元。魚魚並釋放了捕獲的 65%。整體休閒收穫量估計為 3.44 億條魚,重達 3.53 億磅。因此,蓬勃發展的水產養殖業推動了美國北美水產獸醫市場的成長。
2020年9月,維克集團從專門從事研發生物學的動物保健公司Ictyogroup收購了多種羅非魚疫苗。該集團獲得了在全球範圍內分銷和行銷這些註冊自體疫苗的權利。兩家公司建立了合作夥伴關係,為 Aqua Virbac 部門開發新配方和新疫苗。該協議還允許將幾名專門從事技術行銷支援和研發生物學的員工從 Ictyogroup 轉移到維克。
2020 年 7 月,碩騰從 Benchmark Holdings, PLC 收購了 Fish Vet Group,對其製藥業務進行了策略補充。 Zoetis 的製藥業務負責商業化和開發魚類疫苗,並為水產養殖提供疫苗接種和診斷服務。收購 Fish Vet Group 幫助 Zoetis 增強了其診斷專業知識和測試服務,包括 Pharmaq 參考實驗室的環境測試。因此,美國水產養殖業各個市場參與者的策略性舉措支撐了美國的北美水生獸醫市場。
北美水產獸醫市場收入及 2030 年預測(百萬美元)
北美水產獸醫市場細分
北美水生獸醫市場按類型、物種、疾病來源、其他給藥途徑和國家分類。
根據類型,北美水生獸醫市場分為診斷和治療。到 2022 年,治療細分市場將佔據更大的市場佔有率。治療部分進一步細分為疫苗、藥物和補充劑。
依物種分類,北美水生獸醫市場分為魚類、甲殼類、軟體動物等。 2022 年,魚類市場佔據最大的市場佔有率。
根據疾病來源,北美水生獸醫市場分為細菌、病毒、寄生蟲等。 2022 年,細菌細分市場佔據最大的市場。
從給藥途徑來看,北美水產獸醫市場分為水用藥、藥飼料和其他給藥途徑。 2022 年,水藥物領域佔據最大的市場佔有率。
依國家分類,北美水生獸醫市場分為美國、加拿大和墨西哥。 2022年,美國在北美水生獸醫市場佔有率中佔據主導地位。
Aquatic Diagnostics Ltd、Ceva Polchem Pvt Ltd、Elanco Animal Health Inc、HIPRA SA、Merck KGaA、Phibro Animal Health Corp、Thermo Fisher Scientific Inc、Virbac SA 和 Zoetis Inc 是北美水產獸醫市場上的一些領先公司。
The North America aquatic veterinary market was valued at US$ 557.03 million in 2022 and is expected to reach US$ 751.98 million by 2030; it is estimated to register a CAGR of 3.8% from 2022 to 2030.
Government Initiatives to Develop Aquaculture Industry Fuel North America Aquatic Veterinary Market
The high demand for seafood and the decreasing annual catch of wild fish are crucial factors that can drive the growth of the aquaculture industry at an exponential rate. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:
In February 2021, the Foundation for Food & Agriculture Research (FFAR) raised funds of US$ 790,326 to create a vaccine delivery system to prevent the spread of tilapia lake virus infections and other diseases in the aquaculture sector.
Sea Grant Marine Aquaculture Grant Program: This nationwide competitive grant program, officially known as the "National Marine Aquaculture Initiative (NMAI)," promotes research and demonstration initiatives to advance sustainable marine aquaculture in the US.
In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency. Thus, an increase in government initiatives to support developments in the aquaculture industry drives the aquatic veterinary market growth.
North America Aquatic Veterinary Market Overview
According to the National Oceanic and Atmospheric Administration, aquaculture generates ~US$ 1.5 billion annually in the US. The World Bank states that the US produced ~448 thousand metric ton of products out of aquaculture. As per the same source, ~5.6 million fishes were produced by the North American aquaculture industry in 2021, of which the US accounted for the production of ~4.7 million, i.e., ~83% of the total regional fish production. According to the Fisheries of the US 2020 report, commercial fishermen in the US landed 8.4 billion pounds valued at US$ 4.7 billion in 2020. Anglers in the country took nearly 200 million trips for recreational fisheries in 2020. These recreational anglers caught approximately 1 billion fish and released 65% of those caught. The overall recreational harvest was estimated at 344 million fish weighing 353 million pounds. Thus, the flourishing aquaculture industry fuels the growth of the North America aquatic veterinary market in the US.
In September 2020, the Virbac Group acquired various tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology. The group received rights for the distribution and marketing of these registered, autogenous vaccines worldwide. The two companies had a partnership for the development of new formulations and new vaccines for the Aqua Virbac division. The agreement also allowed the transfer of several employees specialized in technical marketing support and R&D biology from Ictyogroup to Virbac.
In July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC to make a strategic addition to its pharma business. The pharmaceutical business of Zoetis commercializes and develops fish vaccines and offers vaccination and diagnostic services for aquaculture. The acquisition of Fish Vet Group helped Zoetis enhance its diagnostics expertise and testing services, including environmental testing, that Pharmaq's reference lab. Thus, strategic initiatives by various market players in the US aquaculture industry bolster the North America aquatic veterinary market in the US.
North America Aquatic Veterinary Market Revenue and Forecast to 2030 (US$ Million)
North America Aquatic Veterinary Market Segmentation
The North America aquatic veterinary market is categorized into type, species, diseases source, other route of administration, and country.
Based on type, the North America aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held a larger market share in 2022. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.
By species, the North America aquatic veterinary market is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest market share in 2022.
Based on diseases source, the North America aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest market share in 2022.
In terms of route of administration, the North America aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest market share in 2022.
By country, the North America aquatic veterinary market is segmented into the US, Canada, and Mexico. The US dominated the North America aquatic veterinary market share in 2022.
Aquatic Diagnostics Ltd, Ceva Polchem Pvt Ltd, Elanco Animal Health Inc, HIPRA SA, Merck KGaA, Phibro Animal Health Corp, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the North America aquatic veterinary market.